Best Stock Hints Latest Tips To Buy & Invest Best Stocks Today
AbbVie is a leading research-driven global biopharmaceutical company. The company produces drugs for several different therapeutic areas such as rheumatology, oncology, virology, neurology, etc.
AbbVie’s blockbuster drug, Humira is one of the best-selling drugs globally and accounts for nearly 60% of the company’s revenue. The drug is used to treat psoriasis and rheumatoid arthritis. Other key products include Lupron, Creon, Androgel, and Marinol. The company also has a robust late-stage pipeline across several therapeutic areas.
Formed as a spin-off from Abbott Laboratories in 2013, AbbVie has a huge worldwide presence. Over 30 million people in more than 175 countries use AbbVie’s products each year.
It has a network of 14 manufacturing facilities and eight research and development centers around the world. The U.S. accounts for over 60% of AbbVie’s revenue while international markets constitute the remaining 40%.
The company has a large distribution network consisting of AbbVie-owned distribution centers and warehouses from where AbbVie’s products reach wholesalers, distributors, and government agencies worldwide. AbbVie operates through only one business segment – Pharmaceuticals.
DISCLOSURE: Please note that links to merchants mentioned within this post might be using an affiliate link. Using an affiliate link means that, at zero cost to you, I might earn a commission if you buy something through that affiliate link.
Key Investment Data
- Ticker: nyse:ABBV
- Sector: Healthcare
- Industry: Drug Manufacturers – General
- Market Cap: 190.38B
- P/E: 9.14
- Dividend Yield: 4.83%
- Payout Ratio (TTM): 137.20%
Competitors
The competitive landscape is important as they compete for the same business. Below is the list of competitors in the same industry.
The below is a sample data set but if you want more data, you can leverage Dividend Snapshot or Stock Rover.
Top Picks By Bay St Experts
Expert stock analysts have shared their opinions on the company.
For more top picks from stock analysts on Bay Street, check the full list of top picks by expect stock analysts from investment and asset management firms.
Not all analysts are equal and they don’t cover the same type of stocks. The analysts performance and ownership is tracked for comparison.
AbbVie Inc – FAQ
What is the stock ticker for AbbVie Inc?
The stock ticker for AbbVie Inc is NYSE:ABBV.
Is AbbVie Inc a good stock to buy?
You need to consider your investment strategy and how NYSE:ABBV can fit in your portfolio.
The current dividend income score of 5/10 and dividend growth score of 5/10. Those 2 metrics together should help you decide the fit for your portfolio. Be it for income or for growth.
Is AbbVie Inc a Buy, Sell or Hold?
The Dividend Snapshot Opportunity Score of 58 out of 100.
The score reflects the strength of a buy signal but it does not show a sell signal if it’s low. The higher the better.
A sell signal is more difficult as it often relies on the reason you bought the stock in the first place.
Source link
